GLP-1R has emerged as a key therapeutic target in obesity and diabetes research, inspiring the development of dual and triple receptor agonists that synergistically enhance glycemic control, promote weight loss, and improve overall metabolic health
[1] This is fundamentally different from the standard medical guidance, which is designed to ramp you up to a high dose to maximize weight-loss outcomes
The SURMOUNT data also showed impressive metabolic improvements
At the time, medical science hadnt figured out how to introduce synthetic GLP-1 into the body in a way where it wouldnt be chewed up
Meals with higher water content, lower viscosity, and a lower glycemic index tend to move through the stomach more easily
Eur J Obstet Gynecol Reprod Biol